America's best-selling supplements and the peer-reviewed evidence behind them, side by side. The gap between the two is, in miniature, the entire argument of this investigation.
No public dataset reports exact profit margins per individual supplement — manufacturers don't disclose that at the ingredient level. What follows instead ranks by market prominence, drawn from 2025–2026 industry data (Nutrition Business Journal, Grand View Research, and NIH consumer-use surveys) — the best available proxy for commercial success — and rates each category against the actual clinical evidence using the same framework this site's books apply throughout: strength of evidence, real-world efficacy, and documented safety.
Before the detailed breakdown, here's the same 25 supplements in their actual sales-rank order, color-coded by evidence tier. Click any entry to jump straight to its full write-up below.
Rather than one flat list, the 25 are grouped into four tiers. The second tier — evidence that's genuinely strong, but only if you're actually deficient — is worth reading closely: it's the single most common gap between what a label implies and what the trial evidence actually supports.
Both make a specific, testable claim rather than a broad promise, and both have held up consistently across large, rigorous trials.
Efficacy: Well-established across decades of research that additional dietary protein, especially post-exercise, supports muscle protein synthesis and recovery in people with adequate training stimulus. The effect is real and replicated, though it's a supplement to an already-adequate diet for most people, not a substitute for one.
Safety: Generally very well tolerated. Some people experience GI discomfort, particularly with whey in those who are lactose-sensitive. People with pre-existing kidney disease should discuss high-protein intake with a physician, though no evidence supports kidney harm in people with normal kidney function.
Efficacy: Among the most rigorously studied compounds in sports nutrition. Consistently shown to improve performance in short-duration, high-intensity activity (sprinting, weightlifting) by increasing phosphocreatine stores available for rapid energy production. Emerging research also suggests modest cognitive benefits under sleep deprivation, though this is less established than the athletic performance evidence.
Safety: Extremely well studied with a strong safety record even at higher doses over years of use. The main documented effect is water retention and modest weight gain from increased muscle water content — not a safety concern, but worth knowing before starting.
This is the single most important tier on this page. Each of these four genuinely works — for the specific population that's actually deficient. Marketed to everyone else, the evidence for benefit collapses.
Efficacy: In someone genuinely deficient, correcting vitamin D levels has real, replicated benefit for bone density and fracture risk. In someone who isn't deficient, the evidence is far weaker: the VITAL trial — nearly 26,000 participants — found no significant reduction in cancer or cardiovascular disease from supplementation, directly contradicting the broadest marketing claims built around this vitamin over the past two decades.
Safety: Very safe at standard doses. Sustained high-dose supplementation can raise blood calcium to levels that affect the heart and kidneys — a genuine risk that has grown more relevant as high-dose vitamin D products have become more popular.
Efficacy: B12 deficiency is real and reasonably common — in older adults, people on certain medications (like metformin), and those following a vegan diet. Correcting a genuine deficiency produces a real, sometimes dramatic improvement in energy and neurological symptoms. In someone whose B12 levels are already normal, supplementation has not been shown to boost energy or mood.
Safety: Very low toxicity; B12 and other B vitamins are water-soluble and excreted efficiently. Essentially no meaningful risk at typical supplemental doses.
Efficacy: For older adults at genuine fracture risk with inadequate dietary intake, calcium supplementation (typically alongside vitamin D) has shown a real, replicated reduction in fracture incidence — one of the more solid findings across this entire list. For people already getting adequate dietary calcium, added supplementation shows little additional benefit.
Safety: Several meta-analyses, including a widely discussed one published in the BMJ, found a modest but real signal of increased cardiovascular risk associated with concentrated supplement-form calcium — a risk not seen with dietary calcium intake at the same levels.
Efficacy: For diagnosed iron-deficiency anemia — common in pregnancy and with heavy menstrual bleeding — supplementation is genuinely corrective and often produces a marked improvement. In someone who isn't deficient, iron supplementation has no demonstrated benefit and simply moves the body toward the excess end of the dose-response curve.
Safety: This is the one entry on this list with a serious acute risk: iron is one of the leading causes of fatal accidental poisoning in young children, because a handful of adult tablets can deliver a toxic dose to a small child. Chronic overload in adults who supplement without a documented deficiency carries real long-term organ risk.
A real, replicated effect exists for each of these — but it's narrower, smaller, or more conditional than the marketing built around it.
Efficacy: The VITAL trial (25,871 participants) found no significant reduction in the overall composite cardiovascular endpoint — but a closer look found a real 28% reduction in heart attack risk specifically, and a 50% reduction in fatal heart attack, with no benefit against stroke. A genuine, narrower benefit than the broad "heart health" claim implies.
Safety: Generally well tolerated. Has an independent blood-thinning effect worth knowing about if combined with a prescribed anticoagulant.
Efficacy: Evidence is genuinely strain-specific — a finding for one probiotic strain and condition (such as reducing antibiotic-associated diarrhea) does not generalize to other strains or claims. Most "general gut health" marketing outpaces what any single product has actually demonstrated.
Safety: Good for most healthy people. Caution is warranted for anyone immunocompromised, where even generally-safe live organisms carry a small documented infection risk.
Efficacy: Reasonable trial evidence supports magnesium for migraine prevention in people prone to migraines. Evidence for the broader "sleep and relaxation" claims driving most of its current sales is considerably thinner and largely limited to people who are magnesium-deficient to begin with.
Safety: Good at typical doses; GI upset (notably loose stools) is the most common side effect. Caution advised for anyone with kidney impairment, who clear magnesium less efficiently.
Efficacy: A growing body of smaller trials shows modest improvement in skin elasticity and hydration, and some benefit for joint comfort in people with osteoarthritis. The evidence base is thinner and newer than most entries in this tier, and results vary meaningfully by the specific peptide formulation used.
Safety: No significant known risks; well tolerated in available studies.
Efficacy: Genuinely effective for circadian-rhythm disruption — jet lag and shift-work sleep issues — where trial evidence is solid. For general chronic insomnia in someone with a normal circadian rhythm, the evidence is considerably weaker than the product's popularity suggests.
Safety: Generally safe at low doses (0.5–3mg). A well-documented, separate problem: independent lab testing has repeatedly found actual melatonin content in commercial products varying wildly from what the label states, sometimes by several hundred percent.
Efficacy: Curcumin has a real, laboratory-demonstrated anti-inflammatory mechanism, but it is very poorly absorbed by the digestive tract in its natural form, which limits how much of the laboratory effect actually translates into a measurable clinical benefit at typical doses.
Safety: Generally well tolerated. Rare case reports of liver injury exist, typically associated with high-dose, high-bioavailability formulations rather than traditional turmeric.
Efficacy: Reasonable evidence supports CoQ10 for reducing muscle pain associated with statin medications, since statins deplete the body's natural CoQ10 production. Some supporting evidence exists as an adjunct therapy in heart failure, though it is not a substitute for standard treatment.
Safety: Good; mild GI effects are the most commonly reported issue.
Efficacy: Reasonable evidence supports a modest reduction in common cold duration when taken at the very onset of symptoms. No credible evidence supports the broader "immune boost" framing — there is no single dial called "immunity" that a nutrient turns up.
Safety: Good at standard doses. Chronic high-dose use is documented to cause copper deficiency, with its own neurological consequences.
Efficacy: A newer but genuinely growing body of randomized trials shows measurable reductions in perceived stress and cortisol levels. It's one of the more promising entries in the herbal category, though the evidence base is smaller and younger than better-established supplements.
Safety: Generally well tolerated in trials. Documented to affect thyroid hormone levels, warranting caution in anyone with thyroid disease, and should be avoided in pregnancy.
Efficacy: Small trials suggest a modest reduction in the duration and severity of cold and flu symptoms when taken early in illness. The trials are generally small, and larger, more rigorous confirmation is still limited.
Safety: Generally safe in properly prepared commercial products. Raw or unripe berries are toxic and must be cooked or processed before consumption. A theoretical concern exists about immune-stimulating effects in people with autoimmune conditions, though this isn't well established.
Efficacy: Modest evidence supports small metabolic and antioxidant effects from concentrated green tea catechins, considerably smaller than the weight-loss claims often attached to this category.
Safety: This is a genuine outlier for safety concern in this tier. A national liver injury registry study found green tea extract implicated in a meaningful share of documented supplement-related liver injury cases — and in 40% of those specific cases, the product's label didn't even list green tea extract as an ingredient, despite lab testing confirming its presence.
Efficacy: Modest, inconsistent evidence supports small reductions in blood pressure and cholesterol with regular garlic extract use — real, but small enough that it shouldn't be relied on as a substitute for prescribed treatment in anyone with diagnosed hypertension or high cholesterol.
Safety: Generally safe. Has a documented blood-thinning effect worth flagging if combined with prescribed anticoagulants or before surgery.
Every entry in this tier is a genuine best-seller. None has strong trial evidence behind the reason most people actually buy it.
Efficacy: Large, well-designed trials — including COSMOS-Mind and the Physicians' Health Study II — have found null-to-modest effects on cognition, cancer, and cardiovascular outcomes in generally well-nourished adults. The "insurance policy" framing doesn't hold up well against the actual trial record for people who already eat a reasonably varied diet.
Safety: Good at standard doses. Risk mainly arises from unknowingly stacking multiple products containing overlapping vitamins and minerals, pushing a person toward the excess end of the dose-response curve without realizing it.
Efficacy: Decades of trials on high-dose vitamin C for cold prevention and duration show minimal effect in the general population — a small benefit has occasionally been shown in people under extreme physical stress (marathon runners, soldiers in extreme cold), which is not the population buying it at the pharmacy checkout counter.
Safety: Very safe; water-soluble and readily excreted, with acute toxicity genuinely rare even at high doses.
Efficacy: The largest, most rigorous trial ever run on this combination — the NIH-funded GAIT trial — found no significant benefit for osteoarthritis pain overall compared to placebo, a genuinely disappointing result for one of the best-selling joint-health products on the market.
Safety: Generally well tolerated. People with shellfish allergies should check the source, since glucosamine is often derived from shellfish shells. Mild interaction with warfarin has been reported.
Efficacy: True biotin deficiency is genuinely rare, and outside of it, no good evidence supports biotin's popular hair, skin, and nail marketing claims. The visible benefit people report correcting a "deficiency" they never actually had is a textbook case of the placebo and confirmation-bias effects documented throughout this investigation.
Safety: Low direct toxicity, but a genuinely important and under-recognized risk: biotin is documented to interfere with common laboratory blood tests, including thyroid panels and the troponin test used to diagnose heart attacks — a real diagnostic safety concern, not just a wasted purchase.
Efficacy: Numerous trials over several decades show a consistent pattern of small, inconsistent effects on cold prevention and duration that most rigorous reviews describe as not clinically meaningful — despite being one of the most extensively tested herbs on this entire list.
Safety: Generally safe. Allergic reactions are possible in people sensitive to ragweed and related plants.
Efficacy: Two large, well-designed trials five years apart — a 225-patient study in the New England Journal of Medicine (2006) and a 369-patient dose-escalation study in JAMA (2011) — both found no improvement in benign prostatic hyperplasia symptoms compared to placebo, at any dose tested. About as clear a negative result as exists in supplement research.
Safety: Well tolerated with minimal reported side effects.
Efficacy: Despite widespread marketing as a "liver support" product, clinical trials on silymarin for liver protection and disease outcomes show inconsistent results, and no major medical organization currently recommends it as a treatment for liver disease.
Safety: Generally well tolerated, with mild GI upset the most commonly reported side effect.
Each entry's efficacy and safety summary reflects the sourced clinical evidence detailed across this investigation's three books, supplemented by the broader peer-reviewed literature for supplements not otherwise covered. See the Annotated Bibliography for individual trial citations.
Six of the twenty-five best-selling supplement categories in America — multivitamins, vitamin C at typical doses, glucosamine/chondroitin, biotin for cosmetic claims, echinacea, and saw palmetto — carry "Weak" strength of evidence for the primary reason people buy them. Several of these are also among the highest-revenue categories in the entire market. Commercial success and clinical support are simply not the same axis, and nothing about a product's shelf placement, price, or popularity moves it from one axis to the other.
The best-evidenced entries on this list — creatine, protein powder, vitamin D and B12 for deficiency correction — share a common feature worth noticing: each makes a narrow, specific, testable claim rather than a broad promise. The weakest-evidenced entries tend to make the broadest claims — general "immune support," general "energy," general "anti-aging." That pattern isn't a coincidence; it's the same mechanism-to-marketing gap this investigation documents chapter after chapter.
"The point was never that nothing in this aisle works. The point is that the confidence with which a product gets chosen and the evidence that actually exists for it are, across case after case, two very different things."Prove It
Market position data drawn from Nutrition Business Journal (2025–2026), Grand View Research, and NIH/CRN consumer-use surveys. Clinical ratings reflect the sourced evidence detailed across all three books in this investigation; see the Annotated Bibliography for individual trial citations.